GSK
Company Type: Therapeutics
Main focus: Development of new therapies for infectious diseases, HIV, respiratory/immunology and oncology
Company stage: Clinical
Diseases: Infectious diseases, HIV, respiratory/immunology and oncology
Genome-editing tool: CRISPR-Cas9, RNA editing
Funding stage: IPO (GSK)
Location: Brentford, UK
Website: https://www.gsk.com/en-gb/
Pipeline: https://www.gsk.com/en-gb/innovation/pipeline/
Partners: Wave Life Sciences, University of California (Jennifer Doudna)
GSK is a global biopharma company with a goal to unite science, technology and talent to advance novel therapies. The company seeks innovation in vaccines and specialty medicines to prevent and treat disease.